Loading clinical trials...
Loading clinical trials...
A Double-blind, Randomized, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects With Idiopathic Generalized Epilepsy
Conditions
Interventions
Lacosamide Tablet
Lasosamide Oral Solution
+2 more
Locations
115
United States
Sp0982 028
Alabaster, Alabama, United States
Sp0982 005
Little Rock, Arkansas, United States
Sp0982 018
Irvine, California, United States
Sp0982 008
Santa Monica, California, United States
Sp0982 031
Colorado Springs, Colorado, United States
Sp0982 035
Denver, Colorado, United States
Start Date
April 1, 2015
Primary Completion Date
April 1, 2019
Completion Date
June 1, 2019
Last Updated
December 17, 2020
NCT02531880
NCT06097195
NCT06315322
NCT06388707
NCT06794606
NCT07505004
Lead Sponsor
UCB BIOSCIENCES, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions